NetworkNewsBreaks – Earth Science Tech Inc. (ETS
Post# of 333
Earth Science Tech (OTCQB: ETST), through its wholly owned subsidiaries, is developing a global presence in the CBD industry. An article discussing the company’s subsidiaries reads, “Cannabis Therapeutics Inc. (‘CTI’) is an emerging biotechnology company that has ventured into the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and leverage the medicinal power of cannabidiol (http://nnw.fm/rW2W5). . . . Canna Inno Laboratories Inc. was formed by Earth Science Tech in 2017 as a strategic Montreal, Canada-based company to give ETST a foothold in Québec and provide the company with access to government grants, the first of which have just been approved (http://nnw.fm/XwB8e). . . . Earth Science Pharma Inc. is an emerging medical research company dedicated to developing leading-edge medical devices and vaccines that will improve the health of women around the world. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs such as chlamydia from a self-obtained gynecological specimen (http://nnw.fm/KnT51).”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer